SIRT1 can also inhibit NF-κB signalling through deacetylation, reduce the expression of lectin-like oxLDL receptor-1 (Lox-1), and reduce the uptake of oxLDL, thus preventing the formation of atherosclerosis [238]. This evidence concerns the gene NFKB1 and atherosclerosis.